Rating History for Karyopharm Therapeutics (KPTI) by Rodman & Renshaw
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/9/2026 | Michael King Jr. | New Coverage | Buy (N/A) |
28.00 (N/A) |
8.77 (9.65) |
10.03% | Details |
